Prognos Health creates a healthcare analytics platform that uses patient-level data to generate clinical insights.
Prognos Health has raised $23.3M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2023.
Prognos Health's investors include Merck, LabCorp, Hikma Ventures, Maywic Select Investments, Red & Blue Ventures.
Prognos Health is headquartered in New York, United States.
Prognos Health creates a healthcare analytics platform that uses patient-level data to generate clinical insights.
Prognos Health is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Prognos Health — Funding & Investors." VCBacked, May 4, 2023, https://www.vcbacked.co/company/prognos-health. Accessed August 15, 2026.
VCBacked. (2023). Prognos Health — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/prognos-health
{{cite web |title=Prognos Health — Funding & Investors |url=https://www.vcbacked.co/company/prognos-health |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated